Exosome therapeutics dev Evox raises $45m in Series B

This article was originally published here

Exosome therapeutics company Evox Therapeutics said today that it raised $45.4 million (GBP £35.5 million) in a Series B round of financing.

The funding round was led by Redmile Group, new investments from GV, formerly known as Google Ventures, and Cowen Healthcare Investments, the Oxford, U.K.-based company said. The round was joined by Panacea Healthcare Venture, Borealis Ventures and existing investors Oxford Sciences Innovation and Oxford University.

Read the whole story on our sister site, Drug Delivery Business News

The post Exosome therapeutics dev Evox raises $45m in Series B appeared first on MassDevice.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply